Evidence map›Paper›PMID 21215366›Full record

ReviewCell2011

Epigenetics in alternative pre-mRNA splicing.

Reini F Luco, Mariano Allo, Ignacio E Schor, Alberto R Kornblihtt, Tom Misteli

Open access · bronzeAbstract readReview
In one paragraph

Review in Cell, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 467 papers.

0numbers the graph read from it
0cells of the map it votes in
467citing papers in PubMed
40.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

467 citing papers in PubMed, 784 citations in OpenAlex.

  1. Article
  2. RNA splicing in health and disease.Molecular biomedicine · 2026
    Review
  3. Review
  4. Article
  5. YTHDC1 recognizes METTL16-dependent mProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Alternative splicing in addiction.Current opinion in genetics & development · 2025
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Archives of medical science : AMS · 2025
    Article

407 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 2 countries.

Reini F LucoNational Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Mariano Allo
Ignacio E Schor
Alberto R Kornblihtt
Tom Misteli
Consejo Nacional de Investigaciones Científicas y Técnicas · ARFundación Ciencias Exactas y Naturales · ARNational Cancer Institute · USNational Institutes of Health · USUniversity of Buenos Aires · AR

Funding

Nuclear Architecture and DiseaseZIABC010309 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MISTELI, THOMAS A · 2009 to 2025
$39.8M
Nuclear architecture and gene expression Z01BC010309 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MISTELI, THOMAS A · 1999 to 2008
$3.6M
Howard Hughes Medical InstituteIntramural NIH HHS Z01 BC010309
6 · The paper itself

Abstract

Alternative splicing plays critical roles in differentiation, development, and disease and is a major source for protein diversity in higher eukaryotes. Analysis of alternative splicing regulation has traditionally focused on RNA sequence elements and their associated splicing factors, but recent provocative studies point to a key function of chromatin structure and histone modifications in alternative splicing regulation. These insights suggest that epigenetic regulation determines not only what parts of the genome are expressed but also how they are spliced.

Indexed as

Alternative SplicingChromatin Assembly and DisassemblyAnimalsEpigenesis, GeneticHistonesHumansRNA PrecursorsTranscription, GeneticHistonesRNA Precursors

Identifiers

PMID21215366
PMCPMC3038581
OpenAlexW2069725730

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.